Skip to content

Helmerich & Payne HP Research and development expense

Research and development expense at other companies

ON Semiconductor logo
ON SemiconductorON
$144.3M-12.1%
TG Therapeutics logo
TG TherapeuticsTGTX
$43.52M+1.1%
Corvex
 logo
Corvex MOVE
$899K+12.4%
Monolithic Power Systems logo
Monolithic Power SystemsMPWR
$100.57M+9.0%
Boston Scientific logo
Boston ScientificBSX
$516M+16.5%
Teradyne, Inc. logo
Teradyne, Inc.TER
$135.56M+14.7%

Other financials

Income statement

See full
Revenue$932.4M-8.2%
Gross profit$271.2M-13.7%
Operating income-$36.9M-188%
Net income-$58.6M-3,643%
EPS (diluted)-$0.59-6,000%

Balance sheet

See full
Cash & equivalents$204.0M-16.7%
Total debt$2.0B-10.6%
Total equity$2.6B-13.8%
Total assets$6.3B-12.5%

Cash flow

See full
Operating cash flow$36.6M-34.7%
CapEx$62.9M-60.4%
Free cash flow$114.9M+121%

Valuation

See full
Market cap$3.56B+41.1%

Profitability

See full
Gross margin31.5%-5.8pp
Operating margin3.3%-13.2pp
Net margin-9.4%-16.5pp
FCF margin4.4%-3.0pp

Returns & leverage

See full
Return on equity-13.2%-20.7pp
Debt / equity0.8×0.0×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Helmerich & Payne in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Helmerich & Payne’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Helmerich & Payne's research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Helmerich & Payne's research and development expense?
Helmerich & Payne (HP) reported research and development expense of $7.02M in Q1 2026.
How has Helmerich & Payne's research and development expense changed year-over-year?
Helmerich & Payne's research and development expense decreased by 25.5% year-over-year, from $9.42M to $7.02M.
What is the long-term trend for Helmerich & Payne's research and development expense?
Over 4 years (2021 to 2025), Helmerich & Payne's research and development expense has grown at a 12.0% compound annual growth rate (CAGR), from $21.72M to $34.12M.